Major Pharmaceuticals: Levothyroxine Sodium Tablets, Usp, 50 Mcg (0.050 Mg), 100 Tablets (10 X 10 Unit Dose Blisters) Per Carton
Major Pharmaceuticals is recalling Levothyroxine Sodium Tablets (50 mcg) in 100-tablet blister packs because the medication is subpotent, meaning it contains less active ingredient than it should. The affected product, distributed nationwide across all U.S. states, is identified by NDC number 0904-6950-61. This recall applies to the prescription thyroid medication packaged and distributed by Major Pharmaceuticals in Indianapolis, Indiana.
- Recalling firm
- Major Pharmaceuticals
- Product
- Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6950-61
- Reason
- Subpotent Drug
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-07-13
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide in the USA.
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/d41d396b-7304-4c29-9168-7ef34edc9b73